Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Agape ATP Corp (NASDAQ:ATPC) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. Agape ATP Corp's stock currently trades…
Read moreQ32 Bio Inc. (NASDAQ:QTTB) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Healthcare company reported annual revenue of and…
Read moreCelularity Inc (NASDAQ:CELU) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. Celularity Inc's stock currently trades…
Read moreRapport Therapeutics, Inc. (NASDAQ:RAPP) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Healthcare company reported annual…
Read moreCitius Pharmaceuticals, Inc. (NASDAQ:CTXR) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. Citius Pharmaceuticals,…
Read moreCullinan Therapeutics, Inc. (NASDAQ:CGEM) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Healthcare company reported annual…
Read moreEQUINIX INC (NASDAQ:EQIX) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. EQUINIX INC's stock currently trades at…
Read moreTENAX THERAPEUTICS, INC. (NASDAQ:TENX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Healthcare company reported annual…
Read moreCartesian Growth Corp III (NASDAQ:CGCT) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. Cartesian Growth Corp III's…
Read moreAerSale Corp (NASDAQ:ASLE) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Industrials company reported annual revenue of…
Read moreCITIUS ONCOLOGY, INC. (NASDAQ:CTOR) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. CITIUS ONCOLOGY, INC.'s stock…
Read moreProtara Therapeutics, Inc. (NASDAQ:TARA) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Healthcare company reported annual…
Read moreSOUTHERN FIRST BANCSHARES INC (NASDAQ:SFST) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. SOUTHERN FIRST BANCSHARES…
Read morePrelude Therapeutics Inc (NASDAQ:PRLD) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Healthcare company reported annual…
Read moreM&T BANK CORP (NYSE:MTB) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on March 10, 2026. The Financial Services company's proxy…
Read moreNEXGEL, INC. (NASDAQ:NXGL) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. NEXGEL, INC.'s stock currently trades at…
Read moreSS Innovations International, Inc. (NASDAQ:SSII) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 10, 2026. The Healthcare company reported…
Read moreDOMINOS PIZZA INC (NASDAQ:DPZ) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on March 10, 2026. The Consumer Cyclical company's proxy…
Read moreOPTICAL CABLE CORP (NASDAQ:OCC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on March 10, 2026. The Technology company reported Q0 revenue of…
Read moreSURO CAPITAL CORP. (NASDAQ:SSSS) filed a Form 8-K with the Securities and Exchange Commission on March 10, 2026, disclosing a material event. SURO CAPITAL CORP.'s stock currently…
Read more
